The receptor tyrosine kinase ephrin type-A receptor 2 (EphA2) is highly expressed in many types of human cancer [3,4,5] but found at very low levels in most normal epithelial tissues, indicating its potential application in cancer therapy. Here, NTRK1 is linked to cancer.